 |
November 04, 2010
Dr. Natalia Zakharova discusses her ESMO funded research evaluating the Eastern Europe breast cancer screening programme, a programme that aims to improve the quality of breast screening. Dr. ...
|
 |
November 01, 2010
Dr Simona Grozinsky-Glasberg speaks about her work with neuroendocrine tumours and explains why she believes that investigating mTOR will be an important step towards developing a successful ...
|
 |
November 01, 2010
Dr Joost Nuyttens speaks about Cyberknife, explaining which cancers can be treated with this technology and how patients are selected. The benefits include the relatively small number of hospital ...
|
 |
November 01, 2010
Prof Nicholas Pavlidis speaks about the effects, prevalence and best ways of detecting and treating cancer of unknown primary origin (CUP). Prof Pavlidis stresses the importance of a correct ...
|
 |
November 01, 2010
Due to the improvements in cancer treatment, more and more people are surviving therapy. Prof Wim van Harten speaks about the importance of dealing with the symptoms and problems experienced ...
|
 |
October 29, 2010
Dr Renata Auriemma speaks about research comparing the short and long term affects of the GH receptor antagonist pegvisomant on acromegaly patient cardiac rhythm. Dr Auriemma explains how ...
|
 |
October 28, 2010
Prof Pierre-Yves Bondiau speaks to ecancer.tv about his research into the use of CyberKnife to treat lung cancer. This radiosurgery tool allows radiation to be targeted extremely accurately and ...
|
 |
October 22, 2010
The managing editor of ecancer gives his highlights from ESMO 2010, Milan 8-12th October 2010.
|
 |
October 22, 2010
Breast sarcoma is a very rare, difficult to manage disease. The Royal Marsden’s experience is reported here from ESSO 2010 in Bordeaux: 63 angiosarcoma patients evaluated for outcome. Call for ...
|
 |
October 21, 2010
Lynda Wyld, Bert Bonsing & Pierre Mordant speak to ecancer.tv about the highlights from the ESSO 2010 meeting. These include talks addressing over-treatment in breast cancer, the importance ...
|
 |
October 21, 2010
Dr Graeme Poston speaks to ecancer.tv about the challenges faced when trying to maintain a constantly high standard of surgery across the UK. Although progress has been made ensuring that surgeons ...
|
 |
October 21, 2010
Managing editor Prof Gordon McVie, from the European Institute of Oncology, speaks to Prof Jean-Yves Blay at ESSO 2010, Bordeaux, about the role of the European Organisation for Research and ...
|
 |
October 21, 2010
Prof Dirk Gouma speaks about his research comparing the use of endoscopic stents with bypass surgery for patients with pancreatic cancer. This study found that patients with a short life ...
|
 |
October 14, 2010
Peter Goodwin speaks to Professor Pat Whitworth about the differences between genomic classifiers, details of the Oncotype DX classifier, establishing which patients require which treatment, gene ...
|
 |
October 06, 2010
Prof Catherine West speaks to ecancer.tv about the radiogenomics consortium. This consortium is a large-scale international pool of genetic data introduced to allow clinicians to predict ...
|
 |
October 06, 2010
Prof Roberto Orecchia talks about techniques and options regarding partial breast irradiation and related issues that have arisen at ESTRO 2010. Prof Orecchia discusses what conclusions can be ...
|
 |
October 06, 2010
Prof Hans Peter Rodemann speaks about his work investigating how inhibition of the EGFR pathway induces resistance to radiotherapy in tumour cells. This research has shown that this signalling ...
|
 |
October 06, 2010
Prof Richard Pötter talks to ecancer.tv about recent advances in gynaecological radiotherapy. The integration of imaging technology into brachytherapy allows the use of much higher doses and for ...
|
 |
October 06, 2010
Stephanie Lang discusses a clinical trial investigating the use of TrueBeam to deliver hyperfractionated treatment to small tumours in the brain and lung. TrueBeam is a new radiosurgery technology ...
|
 |
October 06, 2010
Prof Harry Bartelink speaks about his work with breast conserving therapy and suggests an explanation for data showing that young women with breast cancer have a worse prognosis than older breast ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|